This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • PEACE-3 Trial
      • PROfound Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • ANKTIVA
      • Bladder Cancer Detection
      • CORE-001 Study
      • EV-302
    • Kidney Cancer
      • ZIRCON
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Shilpa Gupta, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Decipher Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular Cancer
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
      • Practice Guidelines Reviews
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • BOND-003 Cohort P
        • CORE-008
        • IMMORTAL
        • PIVOT-006
      • Kidney Cancer
        • RadiCal
        • SAMURAI
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • CLARIFY
        • ECLIPSE
        • ESCAPE
        • FORT
    • Right Side
      • Prostate Cancer
        • METANOVA
        • NRG-GU 0101
        • PROMISE
        • RTIRE
        • SECuRE
        • SHORTER
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2024
      • SCS AUA 2024
      • ASTRO 2024
      • IBCN 2024
      • ESMO 2024
    • All Conferences
      • View All
    • Quick Takes
      • ESMO 2024
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy - Abstract March 16, 2011
Industry-based retrospective cohort study of the risk of prostate cancer among rotating-shift workers - Abstract March 16, 2011
Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry - Abstract March 16, 2011
Inapparent tumor on endorectal multimodality magnetic resonance imaging of prostate: Should we perform a biopsy? - Abstract March 16, 2011
Focal therapy for localized prostate cancer: A phase I/II trial - Abstract March 16, 2011
Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery - Abstract March 16, 2011
Urinary PCA3 score predicts prostate cancer multifocality - Abstract March 16, 2011
A model to predict prostate cancer after atypical findings in initial prostate needle biopsy - Abstract March 16, 2011
Physician assessment of pretreatment functional status: A process-outcomes link - Abstract March 16, 2011
Editor's Commentary - Spirituality and end-of-life care in disadvantaged men dying of prostate cancer March 16, 2011
Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era - Abstract March 15, 2011
Safety profile of robot-assisted radical prostatectomy: A standardized report of complications in 3317 patients - Abstract March 15, 2011
Prostate cancer staging and grading at radical prostatectomy over time - Abstract March 15, 2011
Patients with localised prostate cancer (t1 - t2) show improved overall long-term survival compared to the normal population - Abstract March 15, 2011
Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements - Abstract March 15, 2011
Cone beam CT pre- and post-daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer - Abstract March 15, 2011
Sipuleucel-T: Harbinger of a new age of therapeutics for prostate cancer - Abstract March 15, 2011
Research shows rapid adoption of newer, more expensive prostate cancer treatments March 15, 2011
Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing androgen-deprivation therapy - Abstract March 14, 2011
Epstein criteria for insignificant prostate cancer - Abstract March 14, 2011
Page 1438 of 1451
  • Start
  • Prev
  • 1433
  • 1434
  • 1435
  • 1436
  • 1437
  • 1438
  • 1439
  • 1440
  • 1441
  • 1442
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2025 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free